Gardiner Nathaniel S.

Average Profitability
9.2%
Insider Buys Quantity
3
Insider Buys Sum
$117,529.00
Insider Sells Quantity
2
Insider Sells Sum
$646,352.22

Insider Activity of Gardiner Nathaniel S.

According to the SEC Form 4 filings, Gardiner Nathaniel S., being in a position of

  1. Sr. VP & General Counsel at Enanta Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2412 shares for $23,228,
    over all time since 2015-02-13, has bought 3800 shares for $117,529, and sold 8952 shares for $646,352.

The largest purchase of all time was on 2015-02-17 and amounted to 2000 shares of Enanta Pharmaceuticals, Inc. for $66,644.

The largest sale of all time was on 2019-02-13 and amounted to 6540 shares of Enanta Pharmaceuticals, Inc. for $623,125.

Biography of Gardiner Nathaniel S.

No biography is available at this moment.

2023-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & General Counsel
2,412
0.0117%
$9.63$23,228+32.42%
2019-02-13SaleEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & General Counsel
6,540
0.0332%
$95.28$623,125-25.1%
2016-05-11PurchaseEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & General Counsel
1,000
0.0053%
$24.45$24,445+10.8%
2015-02-17PurchaseEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & General Counsel
2,000
0.0108%
$33.32$66,644+8.97%
2015-02-13PurchaseEnanta Pharmaceuticals, Inc.
ENTA
Sr. VP & General Counsel
800
0.0043%
$33.05$26,440+7.84%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.